BMC Cancer
Journal Abbreviation: BMC CANCER
ISSN: 1471-2407
Publisher: BioMed Central
Publications (98)
Correction to: Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study (BMC Cancer, (2024), 24, 1, (320), 10.1186/s12885-024-12053-8) (2024)
Kollerits B, Gruber S, Steinbrenner I, Schwaiger JP, Weissensteiner H, Schönherr S, Forer L, et al.
Journal article, Erratum
NanoLuc Binary Technology as a methodological approach: an important new tool for studying the localization of androgen receptor and androgen receptor splice variant V7 homo and heterodimers (2024)
Guzman J, Weigelt K, Neumann AD, Tripal P, Schmid B, Winter Z, Palmisano R, et al.
Journal article
Apolipoprotein A-IV concentrations and cancer in a large cohort of chronic kidney disease patients: results from the GCKD study (2024)
Kollerits B, Gruber S, Steinbrenner I, Schwaiger JP, Weissensteiner H, Schönherr S, Forer L, et al.
Journal article
The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype (2024)
Ziegler P, Hartkopf AD, Wallwiener M, Häberle L, Kolberg HC, Hadji P, Tesch H, et al.
Journal article
Synergistic lethality in chronic myeloid leukemia – targeting oxidative phosphorylation and unfolded protein response effectively complements tyrosine kinase inhibitor treatment (2023)
Häselbarth L, Gamali S, Saul D, Krumbholz M, Böttcher-Loschinski R, Böttcher M, Zou D, et al.
Journal article
TIGIT+ NK cells in combination with specific gut microbiota features predict response to checkpoint inhibitor therapy in melanoma patients (2023)
Tsakmaklis A, Farowski F, Zenner R, Lesker TR, Strowig T, Schlößer H, Lehmann J, et al.
Journal article
Neoadjuvant immunotherapy and chemotherapy regimens for the treatment of high-risk, early-stage triple-negative breast cancer: a systematic review and network meta-analysis (2023)
Cortes J, Haiderali A, Huang M, Pan W, Schmid P, Akers KG, Park JE, et al.
Journal article
ATF2 loss promotes 5-FU resistance in colon cancer cells via activation of the ATR-Chk1 damage response pathway (2023)
Yang H, Hübner K, Hampel C, Erlenbach-Wünsch K, Selvamani SB, Shukla V, Geppert CI, et al.
Journal article
The influence of baseline characteristics, treatment and depression on health-related quality of life in patients with multiple myeloma: a prospective observational study (2022)
Fischer J, Knop S, Danhof S, Einsele H, Keller D, Loeffler C
Journal article
Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: the NOA-18 trial (2022)
Wick A, Sander A, Koch M, Bendszus M, Combs S, Haut T, Dormann A, et al.
Journal article